MedPath

To Compare the Safety and Efficacy of Balloon Occluded/Plug Assisted Retrograde Transvenous Obliteration With Endoscopic Variceal Obturation for Primary Prophylaxis of Gastric Varices With Large Spontaneous Shunt

Not Applicable
Completed
Conditions
Liver Cirrhosis
Interventions
Procedure: Balloon occluded/plug assisted retrograde transvenous obliteration.
Procedure: Endoscopic Variceal Obturation
Registration Number
NCT05677230
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Brief Summary

Study population: All the consecutive patients of cirrhosis who are diagnosed to have large gastric varices without prior history of bleeding from GV, who came to OPD or endoscopy in Hepatology department of ILBS will be evaluated for inclusion.

Study design: Prospective interventional study. The study will be conducted in the Department of Hepatology ILBS.

Study period: 1.0 years

Sample size: 42

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
56
Inclusion Criteria
  1. Age 18-75 years
  2. Cirrhotic patients, with GV (GOV2 or IGV1) with eradicated or small low risk esophageal varices with gastrorenal shunt of >10 mm size amenable for BRTO/PARTO.
Exclusion Criteria
  1. Non-cirrhotic portal hypertension,
  2. History of bleeding from GV
  3. Hepatic encephalopathy grade III/IV,
  4. Acute kidney injury
  5. Patients on beta blocker therapy for > 6 months prior to enrollment in study
  6. Hepatocellular carcinoma
  7. Portal venous thrombosis
  8. Presence of jaundice (bilirubin >3 mg/dl), ascites, Child C, MELD > 18
  9. Advanced cardiac or pulmonary diseases
  10. Pregnancy
  11. Patients not giving informed consent

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Balloon Occluded/plug assisted Retrograde Transvenous Obliteration.Balloon occluded/plug assisted retrograde transvenous obliteration.Balloon occluded/plug assisted retrograde transvenous obliteration will be done one time only.
Endoscopic Variceal ObturationEndoscopic Variceal Obturationendoscopic variceal glue therapy will be done till obturation every 3 weekly.
Primary Outcome Measures
NameTimeMethod
Proportion of patient having bleeding from GV at 12 months6 months
Secondary Outcome Measures
NameTimeMethod
Proportion of patients achieving complete or partial obturation of GV6 months
Proportion of patients having change in grade of EV and bleeding from EV6 months
Proportion of patients having appearance or worsening of PHG6 months
Change in HVPG in those patients who bleed after BRTO/PRTO6 months
Change in HVPG in those patients who bleed after EVO6 months
Change in liver (in KPa) and splenic stiffness (in KPa) after BRTO/PRTO using transient elastography6 months
Change in liver (in KPa) and splenic stiffness (in KPa) after using transient elastography6 months
Proportion of patients having new onset decompensation with ascites, jaundice or hepatic encephalopathy6 months
Proportion of patient developing post procedure liver failure6 months
Proportion of patient developing post acute kidney injury or sepsis6 months
Duration of hospital stay poof procedure12 months
Evaluation of expertise of endoscopists12 months
Any variceal bleed12 months

Trial Locations

Locations (1)

Institute of Liver & Biliary Sciences

🇮🇳

New Delhi, Delhi, India

© Copyright 2025. All Rights Reserved by MedPath